Aim: To evaluate the importance of Heat shock protein 27 (HSP27) and Atherogenic Index of the Plasma (AIP) in diabetic subjects, as indicators of cardiovascular disease progression in diabetic subjects.
Introduction
Cardiovascular complications have become a major cause of death in the world, accounting for nearly 31% of deaths in 2015 according to WHO. Most important risk factors include obesity, lack of physical activity, smoking, hypertension and disarrayed lipid metabolism. Dyslipidaemia has been identified as a marker that can predict the risk of occurrence of type 2 diabetes mellitus and its associated complications [1] . Altered lipid parameters in diabetic conditions and derived lipid ratios can give useful insights towards atherogenic plaque formation and cardiovascular complications. Atherogenic index of the plasma (AIP) is defined as log 10 (Triglyceride / HDL cholesterol),both parameters expressed as molar concentrations, and is considered
The role of lipids in accelerating cardiovascular complications is unequivocal. Long term diabetes mellitus results in a disarrayed metabolism of lipids, accumulation of triglycerides and low and very low density lipoproteins (LDL and VLDL). A corollary to this effect is increase in the levels of oxidized LDL cholesterol which is instrumental in accelerating the rate of plaque formation [3] . AIP has been used as a measurable entity for associating the risk of cardiovascular diseases in diabetic subjects along with the most commonly used Framingham Risk Score (FRS) [4] [5] [6] . Another study in subjects with coronary artery disease in Asian population has identified that AIP could be used for discrimination between subjects affected with coronary artery disease [7] . The possibility of using AIP as a discriminatory score in the early and advanced diabetic subjects, for assessing the risk of cardiovascular disease will not only improve the management of diabetes in the subjects, but also prevent the ensuing risk of cardiovascular diseases [8] .
Heat shock protein 27 (HSP27)belongs to the conserved class of small molecular weight chaperone proteins. They play a unique role in stabilization of the act in filaments , prevent the irreversible aggregation of unfolded proteins and confer resistance to cells during oxidative stress [9] [10] [11] .HSP27 has been attributed to play important roles in diabetes mellitus and in atherogenic plaque formation as well [12, 13] . One study has reported an increase in the levels of HSP27 in the serum of subjects with acute coronary syndrome as compared to the healthy controls in their study. They further report that the plaque region showed a characteristically lower concentration of this protein [14] . A seemingly contradictory observation has also been reported where in HSP27 levels were found to be higher in healthy individuals when compared to subjects suffering from coronary artery disease [15] .
The purpose of our study was to identify whether the duration of diabetes (early stage and long term) had any influence on the levels of HSP27 in the serum of diabetic subjects. We also wanted to ascertain whether there was any correlation between AIP and the concentration of HSP27 in the serum of diabetic subjects. Such correlations could be useful indicators to evaluate the risk of atherogenic plaque formation and the progression of cardiovascular complications in type 2 diabetic subjects.
Materials and Methods

Ethical issues
The study was conducted upon the approval of the Scientific Advisory Committee of the Sir H.N. Medical Research Society, Sir H.N. Hospital and Research Centre, Mumbai, India. The procedures used in this study were carried according to the guidelines set by the ICMR for conducting research on human volunteers, which was in accordance to the Helsinki declaration, 2008.
Study design
Selection and description of participants 144 subjects, age > 40 years, were selected for our study. After obtaining the informed consent from these subjects, their details were entered in the clinical proforma. The volunteers were divided into 4 groups; Group A1 = diabetic > 5years with hypertension (N = 55); Group A2 = diabetic< 2 years, without hypertension (N = 28); Group B1 = hypertensive (N = 31) and Group B2 = healthy controls (N = 30). The norms for designation of diabetes and hypertension were followed according to American Diabetes Association (ADA) guidelines and the Joint National Committee (JNC) 7 guidelines respectively.
Exclusion criteria
Subjects below 40 years, and with major systemic illness, chronic inflammatory diseases and autoimmune diseases were excluded from the study.
Procurement of Serum samples
Venous blood was obtained using standard venepuncture procedures and serum thus obtained, was divided into set of 5 aliquots and stored at -80 o C till further assay.
Physical parameters like BMI, Waist: Hip ratio and Blood pressures (systolic and diastolic) were measured using standard protocols. Biochemical parameters of the volunteers were estimated using Konelab 20 i auto analyser.
ELISA studies
Ready to use ELISA kits were purchased and used for the estimation of Heat shock protein 27 (HSP27) (R&D systems Minneapolis, US). All reagents and serum samples were brought to room temperature (freeze thaw cycles were avoided) and diluted as per kit instructions. Standards were prepared and ELISA assays were performed according to the instructions provided by the manufacturers. Serum samples were diluted (if required), to obtain absorbance values in agreement with the standard graph. Intra and inter assay controls were maintained in all ELISA experiments.
AIP was calculated as Log (Triglycerides / HDL cholesterol), both expressed in mmol/L, and compared with the reference groups for assessment of risks.
Statistics
Standard graphs were plotted using Curve Expert 1.4 software and concentrations in the unknown serum were determined using 4th degree polynomial regression and taking the dilutions used into account. The results were analysed using IBM SPSS software version 21. Mean ± SD were reported for all parameters in the study groups. Normality of the data was confirmed using Kolmogorov-Smirnov test. Distribution of the mean values across the groups was confirmed using ANOVA and the KruskalWallis test. Inter-group comparisons were performed using the Independent t Test or Mann-Whitney U test and significant deviations were identified with 95% confidence interval limits. Correlations between the parameters in question and the groups in study was established using the Pearson's correlation coefficient or the Kendall rank correlation coefficient. Multiple linear regression was used to identify the parameters which possess greater prediction value. ROC curves were obtained to identify Area under the Curve (AuC), and discriminating values were identified for FRS, HSP27 and AIP scores.
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Copyright: © 2017 Deo SS, et al. Table 1 depicts the results of anthropometric study, biochemical analyses and ELISA results for HSP27in our study groups. There was a significant increase in blood pressures (systolic and diastolic), blood sugar (fasting and post-prandial), Triglycerides; Total and LDL cholesterol as well as HbA1c among the diabetic groups (p< 0.05). Serum levels of HSP27 were found to be significantly elevated in the diabetic subjects when compared with the healthy controls, (p = 0.001 and 0.025 respectively); and hypertensive group, (p = 0.003 and 0.043 respectively). Framingham Risk Score (FRS) was found to be significant across all the groups. We saw significant differences between all the groups (p = 0.000), except between diabetic and hypertensive groups. Although AIP values did not show any statistically significant difference across the groups, we saw an increase in the number of individuals having AIP value > 0.21 in Group A1 and Group A2 as compared to the control group, as seen in Figure 1 . Values in Table 1 Figure 1 , the vertical line intersecting the X-axis is the AIP score of 0.21, which represents an increased risk of cardiovascular complications. The figure shows an increase in the number of subjects with AIP scores > 0.21 in the diabetes and hypertensive groups (Groups A1 and A2) as compared to the control group (Group B2). Table 2 Table 3 represents two multivariate regression models that reveal HSP27as a strong independent variable, which influences AIP (t = -2.332, p = 0.021, 95% CI from -0.256 to -0.021) along with post prandial blood sugar (t = 2.307, p = 0.023, 95% CI from 0.000 to 0.001), after adjusting for Age, BMI and Gender.
Results
Figures 3a and 3b, are Receiver Operating Characteristics (ROC) curves which were obtained using a cut-off value of 156mg / dl (Mean ±2SD of the control group) for PPBS.
As seen in Figure 3a , a discriminatory score of FRS = 49.5 was obtained with Area under the Curve(A u C) = 0.731, SE = 0.043, p = 0.000; 95% confidence interval (CI) of 0.646 and 0.815whichcorresponded to the concentrations of HSP27 = 0.445 ng / ml; (A u C) = 0.606, SE = 0.047, p = 0.028, with 95% CI of 0.513 and 0.699. AIP scores were non-significant as a test for discriminating the risk of cardiovascular complications in diabetic subjects.
When the diabetic groups (Groups A1 and A2) were combined together and compared with the non-diabetic groups (Groups B1 and B2), as seen in Figure 3b , a discriminatory score of FRS = 41.5 was obtained with (A u C)= 0.849, SE = 0.033, p = 0.000; 95% In Table 3 , two models of regression are depicted. In both the models, HSP27 and Postprandial blood sugar levels are seen to be very strong predicting factors of AIP. Age, BMI and Gender are not significant in predicting AIP.
Figure 2:
Scatter plot depicting the relation between AIP scores and HSP27 In Figure 2 , we can see that HSP27 is negatively correlated with AIP score. The coefficient of determination R2 = 0.03. HSP27 can account for 3% of the variability seen in the AIP score. HSP27 exhibits a linear relationship with AIP score.
Figure 3a:
Receiver Operating Characteristics (ROC) curve for HSP27, FRS and AIP score for study groups Figure 3a represents ROC curves of FRS, HSP27 and AIP for the study population. Post prandial blood sugar = 156mg / dl (Mean ±2SD of the control group) was used as a cut off value. The A U C value for FRS was 0.731 (p = 0.000, 95% CI from 0.646 to 0.815) and for HSP27 was 0.606 (p = 0.028, 95% CI from 0.513 to 0.699) respectively. The discriminatory values obtained from these ROC curves were 49.5 for FRS and 0.445 ng/ ml for HSP27.
Discussions
Diabetic subjects have been reported to have a greater risk of myocardial infarction due to altered lipid profiles [16] . Our study focussed on the impact of short and long-term diabetes on AIP score and HSP27 in our subjects. Our results validate that FRS is a good indicator of the risk of cardiovascular diseases in diabetic subjects. This has been in consonance to one such study published in north Indian population [17] . In our study, we found increasing number of subjects with diabetes having AIP scores > 0.21 as compared to the controls. We did not however find statistical significance in the distribution of AIP scores in our subjects. This is contrary to many reports published in diabetic subjects [18, 19, 20] . AIP score has been reported to reduce in type 2 diabetes subjects due to reduction of serum triglycerides, and due to treatment of diabetic subjects using pioglitazone, Tracking the increase and decrease in the AIP score can be of clinical significance for the assessment of cardiovascular complications in diabetic subjects [21, 22] .
We also found that HSP27 is indeed significantly increased in the subjects with diabetes, with or without hypertension (Groups A1 and A2), when compared with the controls (Group B2). This has also been reported in one such study [23] . Our results demonstrate that HSP27 has a negative correlation with AIP score. This could be probably because HSP27 has a protective function, in chaperoning various enzymes needed for metabolism, or in reducing the ROS load generated during the pathophysiology of diabetes [11] . The ROC curve demonstrates that FRS has the highest Area under the curve (A U C), which was 70.1%, followed by HSP27, which was 60.6%. AIP score exhibited an A U C which was non-significant. The cut-off value of 0.435 ng/ ml for HSP27, which we obtained using the ROC curve, can be validated using a larger study population, and can be considered in regular clinical evaluation.
Thus we conclude that HSP27 is surely a very important molecule to monitor during early stages of diabetes (i.e. up to 2 years), as well as in long term diabetes, (i.e. > 5 years), as it positively correlates with Atherogenesis and cardiovascular complications. Negative correlation of AIP with HSP27 emphasizes the important role of HSP27 in preventing plaque formation and reducing the risk of cardiovascular complications. It has been reported that areas of myocardial infarcts show a marked reduction in the concentration of HSP27 in comparison to the nearby healthy tissue areas [24] . An increase in the circulating levels of HSP27 could probably be associated with maintaining homeostasis and reversing the damage caused by diabetes. But as the disease progresses, the levels of HSP27 in the cardiac tissues reduce to values which can cause apoptosis of cells [14] .
Conclusion
The limitation of our study is the modest number of subjects recruited. This can be alleviated by corroborating this study with a larger population, especially in diabetic subjects in the age group of 30 -40 years, and in subjects identified with type 2 diabetes less than 2 years.
Considering the fact that various systemic and metabolic diseases like diabetes eventually manifest into heart ailments, early diagnosis of cardiovascular risks is the need of the hour. Our cross-sectional study attempts to add value to the existing information in the field of early diagnosis of cardiovascular complications in diabetic subjects. We conclude by emphasizing that HSP27 and AIP score has a great potential to be included in regular clinical diagnosis and monitoring circulating levels of HSP27 and AIP scores in early and long-term diabetic subjects could improve the detection of cardiovascular risk in diabetic subjects, thus reducing the morbidity and mortality found in these subjects.
